文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Teresa McClendon
发表
Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse.
A. Nademanee, P. Stiff, V. Bachanova, 2018, Blood.